NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	CML
Date of first enrollment	06/09/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Interferon alpha-nl INN of investigational material : Therapeutic category code : 639 Other biological preparations Dosage and Administration for Investigational material : SC

Outcome(s)

Primary Outcome	Efficacy/safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 15age old
Age maximum	<= 74age old
Gender	Both
Include criteria	Patients with CML, aged between 15 and 74 years, inclusive, at time of consent
Exclude criteria